International Networks of Excellence Program in Acute Rheumatic Fever Biomarker Project

Acute rheumatic fever initiates a slow but progressive process of heart valve damage termed rheumatic heart disease. The challenge for the applicants is to identify a biomarker(s) for acute rheumatic fever that can serve as a basis for a test or panel of tests to accurately distinguish patients with acute rheumatic fever from individuals who do not have acute rheumatic fever.

*Network members must be from at least two continents*

**Multidisciplinary teams are a must**

It is expected that one (1) award will be granted. 

Funding: $8,000,000 total 

Duration: 5 years

Research Authority due date: 13.1.22

LOI (required) due date: 21.1.22

Full application due date: May 2022